{
  "id": 3329549,
  "title": "Why is Synopsys stock rallying today?",
  "url": "https://urgent.news/2026/08/25/why-is-synopsys-stock-rallying-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-25T18:58:54.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/why-is-synopsys-stock-rallying-today-93CH-4875841"
  },
  "original_language": "en",
  "account": "Synopsys stock experienced a 3.0% increase during afternoon trading, as investors anticipated the company's fiscal third-quarter 2026 earnings release, set for after market close on August 26. Rosenblatt Securities issued a bullish pre-earnings note, maintaining a Buy rating and raising the price target to $575. The analyst forecasted quarterly revenue of approximately $2.435 billion, which reflects around 40% year-over-year growth. Favorable trends in the electronic design automation industry and the rising use of Synopsys's AI-driven design tools were highlighted as significant growth drivers.\n\nThe company's recent performance has been robust, with beating consensus estimates in the last two quarters, raising full-year guidance multiple times, and maintaining a substantial $11 billion backlog. Management's Q3 guidance anticipates revenue between $2.41 billion and $2.46 billion, and non-GAAP EPS of $3.63 to $3.69, surpassing the high expectations set by previous reports.\n\nThe market reaction has been positive, with the broader analyst community maintaining an average price target around $560, which is higher than today's trading level. Activist investor Elliott Management recently disclosed a new stake in Synopsys. The broader Nasdaq Composite advanced 0.6% and the S&P 500 gained 0.3% during the session, indicating a generally risk-on sentiment that benefited technology and semiconductor-adjacent stocks.\n\nSynopsys's main competitor, Cadence Design Systems, has seen a slower growth rate recently, which has drawn attention to what analysts consider a valuation advantage for Synopsys. All these factors combined—timely analyst endorsement, strong pre-earnings positioning, and a favorable market environment—along with the stock's proximity to its 52-week low of $366, have created a compelling setup for investors ahead of the upcoming earnings report. This report was produced with AI assistance and reviewed by an editor.",
  "summary": null,
  "key_points": [
    "Synopsys stock rose 3.0% ahead of Q3 2026 earnings release on Aug 26",
    "Rosenblatt Securities upgraded rating to Buy and raised price target to $575",
    "Analyst forecasts 40% YoY revenue growth at $2.435 billion"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}